Intracerebral haemorrhage, ageing, quality of life, death, dependency
Introduction
The consequences of intracerebral haemorrhage (ICH) are often devastating and treatment options are limited. [1, 2] Management is directed at limiting expansion and/or mass effect of the haematoma, reducing further brain injury, preventing the complications of disability, and enhancing recovery. [3] Population and targeted treatment of elevated blood pressure (BP) has led to reductions in the age-specific incidence of ICH (and ischaemic stroke) in established market economy countries but rates continue to rise in low and middle income countries. [4] [5] [6] [7] However, data on the incidence, case fatality and functional outcomes from ICH are scarce in specific demographic subgroups [8] , and particularly so in older people, the fastest growing subgroup of many populations in the world. [5] It is important, therefore, to understand the profile and impact of ICH in older people.
We aimed to investigate the association of age with the severity of ICH, and with the specific outcomes of death and major disability (or 'dependency'), physical functioning, healthrelated quality of life (HRQoL), and death alone among participants of the large-scale INTERACT2 study of early intensive BP lowering in ICH. Our hypothesis was that increasing age would be associated with clinically important differences in the characteristics and outcomes of ICH.
Methods
The design and main results of the INTERACT2 study have been described elsewhere. [9, 10] In brief, INTERACT2 was an international, multicentre, randomised controlled trial comparing early intensive (target systolic BP [SBP] of <140 mmHg within 1 hour of randomisation) with guideline-recommended (target SBP <180 mmHg) BP control in 2839 adult patients with spontaneous ICH within 6 hours and elevated SBP (150-220mmHg) from history including current treatment for cardiovascular disease, were recorded at inclusion (i.e. baseline assessment). Patients were excluded if they had a definite indication for, or contraindication to, intensive BP lowering treatment, a structural cerebral cause for the ICH, deep coma (scores 3-5 on the Glasgow Coma Scale [GCS]) or massive haematoma with a poor prognosis, or if early surgery was planned to evacuate the haematoma. The study complied with the Declaration of Helsinki, locally appointed ethics committee approved the research protocol for each site, and informed consent was obtained from all patients or relevant surrogates.
Stroke severity was assessed using the National Institutes of Health Stroke Scale (NIHSS). [11] The primary outcome measure was a poor outcome, defined as death or major disability (defined as a score of 3 to 6 on the modified Rankin Scale [mRS] [12] ) at 90 days post-randomisation. The key secondary outcome was physical function across all seven levels of the mRS, as determined by an ordinal analysis. Health-related quality of life (HRQoL) was assessed with the European Quality of Life -5 Dimensions (EQ-5D) questionnaire. [13] For this analysis of the INTERACT2 cohort, participants were divided into five (quintiles) age groups. Differences in baseline characteristics between age groups were assessed using a simple linear regression model. Associations between age category and primary outcome (death or dependency: mRS score 3-6), and secondary outcomes; death, dependency alone and HRQoL [EQ-5D scores dichotomised to 'any problems' vs 'no problems'] were analysed with logistic regression, and reported as an odds ratio (OR) with associated 95% confidence intervals (CI). An ordinal regression was used to evaluate the key secondary outcome (physical function across seven levels of the mRS). [14] Statistical significance was set at a pvalue <0.05. SPSS Statistics 21, SAS software version 9.3, and the STATA software version 13.0, were used for analyses.
Results
Of the 2839 study participants, 2794 with 90-day follow up data were included, 1753 (62.9%) of whom were male. Overall mean age of participants was 63.6±12.8 years (range 22.6-99.4 years); males were younger than females (62.7±12.7 versus 65.0±13.0 year, p <0.001). Most (68%) participants were from China, and they were younger compared to those from other countries. However, there were no clear difference in the effect on the primary outcome by age between recruitment regional subgroups (P=0.169 for homogeneity). Table 1 shows there were differences in the baseline characteristics across the age quintiles.
NIHSS scores progressively increased with increasing age categories. Lobar location and presence of intraventricular extension were also more common in the categories of older age.
Current use of antihypertensives was significantly less frequent in the categories of younger age but there was no association of age with history of ICH or hypertension. Table 2 shows that increasing age was associated with increasing frequency of death or dependency (multivariable adjusted OR 4.36, 95% CI 3.12-6.08 for >75 years vs <52 years, p trend <0.001) and decreasing HRQoL, including problems with mobility, self-care, usual activities, depression (all p trend <0.001), and pain or discomfort (p trend 0.022). The association between age and death or dependency remained significant even after further adjustment for admission to an intensive care unit and for withdrawal from active care (P <0.001 for trend). Similar results were obtained also when stratifying by median time from ICH onset to baseline CT and in the use of current antithrombotic treatment at baseline assessment. The key secondary outcome, physical function across seven levels of the mRS, worsened across increasing age categories (p value trend <0.001), with those over 75 years of age having a greater than 5 fold odds of worse physical function, or death) OR 5.52 (4.31-7.06). Figure 1 shows multivariable adjusted ORs across age groups for the primary outcome.
Discussion
This study has shown that older adults with acute ICH experience worse outcomes compared to their younger counterparts, including death, dependency, and HRQoL. Although based on a selected clinical trial population, this study has shown an association of ageing with several clinical factors shown to be individually connected to poor outcome, such as stroke severity (defined by high NIHSS score), haematoma characteristics (including intraventricular extension), co-morbid cardiovascular disease, diabetes mellitus or prior antithrombotic therapy (Table 1) . [15, 16] Data on functional outcome after ICH are limited in elderly patients. [8] A meta-analysis found a striking increase in loss of disability-adjusted life-years (DALYs) in people aged 75 years and more. [4] We have shown a strong association between worse functional outcome, defined by the mRS, and increasing age. While lobar ICH and recurrent ICH are more common in the elderly due to greater use of antithrombotic agents and prevalence of cerebral amyloid angiopathy, [7, 17, 18] most patients across all age groups experienced deep location ICH, even though this is more common in younger people. Haematoma volume was greater in younger patients whereas NIHSS scores were higher in old patients. This apparent discrepancy may be explained by differences in the site of the haematoma in the young compared to the old, and more intraventricular extension in older people. It could also be argued that older people may have less "cerebral reserve". Asian people have a higher proportion of hypertension-related ICH, [19] whereas Western people have a higher proportion of cortical ICH, potentially related to amyloid angiopathy and antithrombotic related ICH. [17, 18] This may account for the observed differences in associations concerning younger ICH patients in the Chinese subgroup. Antihypertensive drugs were more commonly used in elderly people, but history of hypertension was equally common across age groups, suggesting that younger hypertensive subjects had less adequate BP treatment. Increasing age Age, a strong predictor for poor outcome after ICH.
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7 has been found to be related to worse HRQoL after stroke, [20, 21] a finding confirmed in the INTERACT2 cohort, where almost half of those over the age of 75 years had problems with anxiety or depression. Previous studies have shown that older stroke patients are more likely to experience depression, [22, 23] even among those who are considered to have recovered fully physically. [21] Depressive symptoms, together with decreased social support, contribute to lower health status even after adjustment for physical functioning and stroke severity, [21] which emphasises the importance of recognising and addressing depressive symptoms.
Strengths of this study include the large prospective cohort design with very low loss to follow-up. Furthermore, a wide range of patient characteristics and health care settings were involved increasing generalizability. Rigorous evaluation of outcomes helped ensure reliability. However, a major limitation was the exclusion of those patients with poor prognosis, which may have restricted the inclusion of elderly patients with severe ICH.
In conclusion, older age was strongly associated with the initial ICH severity, and with subsequent poor outcomes, including death or major disability at 90 days. Our data will help guide clinicians in discussion with patients and their families about the likely outcomes in the acute phase of ICH.
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